Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against STAAR Surgical Company. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Why Is STAAR Surgical Company (STAA) Under Investigation?
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of STAAR Surgical Company (“STAAR” or “the Company”) (NASDAQ: STAA). Investors who purchased STAAR securities are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether STAAR has violated federal securities laws.
What Potential Securities Violations Is BG&G Investigating?
On February 11, 2025, STAAR issued a press release reporting its financial results for the fourth quarter and full year 2024. Among other items, for the quarter, STAAR reported GAAP earnings per share of -$0.69, missing consensus estimates by $0.55, and revenue of $48.95 million, missing consensus estimates by $28.52 million. The Company attributed its results to “fluctuating demand in China”. On this news, STAAR’s stock price fell $5.40 per share, or 24.68%, to close at $16.48 per share on February 12, 2025.
What’s Next?
If you are aware of any facts relating to this investigation or purchased STAAR securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660
How Is STAAR Surgical Company (NASDAQ: STAA) Stock Trading Today?
How Does BG&G Help Investors in Securities Fraud Investigations?
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”